CD44 and breast cancer: This is supported by the fact that the expression of MMP14 and CD44 is reduced and the migration of cells in basal breast cancer is reduced by knockdown of Ubc9 and PIAS1, which suggests that SUMOylation has a significant effect on the stability of CD44 (128, 129).